![EASD 2021: Reconciling the International Consensus Reports for LADA and Type 1. Part 1: Diagnosis – The Practical Diabetic EASD 2021: Reconciling the International Consensus Reports for LADA and Type 1. Part 1: Diagnosis – The Practical Diabetic](https://practicaldiabetic.files.wordpress.com/2021/10/image-1.png?w=651)
EASD 2021: Reconciling the International Consensus Reports for LADA and Type 1. Part 1: Diagnosis – The Practical Diabetic
![The clinical consequences of heterogeneity within and between different diabetes types | SpringerLink The clinical consequences of heterogeneity within and between different diabetes types | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-020-05211-7/MediaObjects/125_2020_5211_Fig2_HTML.png)
The clinical consequences of heterogeneity within and between different diabetes types | SpringerLink
![Autoantibodies against ZnT8 are rare in Central-European LADA patients and absent in MODY patients, including those positive for other autoantibodies - ScienceDirect Autoantibodies against ZnT8 are rare in Central-European LADA patients and absent in MODY patients, including those positive for other autoantibodies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S105687271830518X-gr2.jpg)
Autoantibodies against ZnT8 are rare in Central-European LADA patients and absent in MODY patients, including those positive for other autoantibodies - ScienceDirect
![LADA latent autoimmune diabetes in adults endocrinoloog diabetoloog hasselt dokter Jamal Belkhouribchia LADA latent autoimmune diabetes in adults endocrinoloog diabetoloog hasselt dokter Jamal Belkhouribchia](https://drbelkhouribchia.be/____impro/1/onewebmedia/LADA%201.png?etag=W%2F%228fa6-58001eb6%22&sourceContentType=image%2Fpng&ignoreAspectRatio&resize=623%2B353&extract=0%2B0%2B623%2B352)